Thyomsin alpha 1 for covid

[Cheapshot]

For the ones who still believe covid is real..lol. has anyone done any research on this? Looks like it actually works to get over covid quicker and less deaths. Cant believe I haven't heard of it before, cuas3 it helps with hepatitis, cancer and hiv, some pretty serious diseases. Its a peptide with 28 aminos.boosts the immune system.I will post some interesting links I have found. I might pick some up just in case.

 

[Cheapshot]

Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells - PubMed

Tα1 treatment significantly reduced mortality of severe COVID-19 patients. COVID-19 patients with counts of CD8+ T cells or CD4+ T cells in circulation less than 400/μL or 650/μL, respectively, gained more benefits from Tα1. Tα1 reversed T-cell exhaustion and recovered immune reconstitution...

pubmed.ncbi.nlm.nih.gov

Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells — Immunology

www.immunology.ox.ac.uk

I dont know why I cant find the others. I need to save more stuff..lol

 

[Goldenrod]

yes, I posted on another forum about this a few weeks ago. Basically, it was being used in high risk population for infection (old folks homes). I will see if I can find it but it sounded promising.

 

[Goldenrod]

Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells

Thymosin alpha 1 reduced the mortality of severe coronavirus disease 2019 (COVID-19) by restoration of lymphocytopenia and reversion of exhausted T cells. COVID

academic.oup.com

Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases

Thymosin alpha 1 (Tα1) is a powerful modulator of immunity and inflammation. Despite years of studies, there are a few reports evaluating serum Tα1 in health and disease. We studied a cohort of healthy individuals in comparison with patients ...

www.ncbi.nlm.nih.gov